(Press-News.org) (MEMPHIS, Tenn. – September 24, 2014) St. Jude Children's Research Hospital investigators found that adjusting treatment based on early response to chemotherapy made a life-saving difference to young patients with an acute lymphoblastic leukemia (ALL) subtype associated with a poor outcome. The study appeared in the September 20 edition of the Journal of Clinical Oncology.
The results are good news for children and adolescents with Philadelphia chromosome-like ALL (Ph-like ALL), a subtype that until now was associated with a poor prognosis. Ph-like ALL accounts for as much as 15 percent of the most common pediatric cancer. That cancer is called B-ALL because it affects white blood cells called B lymphocytes.
The study involved 344 children and adolescents with B-ALL, including 40 with the Ph-like ALL subtype. All were enrolled in a St. Jude clinical trial that used risk-directed chemotherapy. The approach relied on a method pioneered at St. Jude to monitor and adjust treatment intensity based on the percentage of leukemic cells – or minimal residual disease (MRD) –in patient bone marrow at days 19 and 42 of chemotherapy.
Using MRD-based, risk-directed chemotherapy therapy, patients in this study had high rates of long-term and cancer-free survival regardless of their leukemia subtype. Overall, 92.5 percent of patients with Ph-like ALL in this study were alive five years after their cancer was discovered compared to 95.1 percent of other B-ALL patients.
"This study shows that by measuring minimal residual disease and using the results to guide treatment intensity, patients with Ph-like ALL can enjoy the same high rates of survival as other patients," said the study's corresponding author Ching Hon-Pui, M.D., chair of the St. Jude Department of Oncology.
When available, more sophisticated genetic testing should be used to identify which of the B-ALL patients with high levels of MRD have the Ph-like ALL subtype, Pui said. That is because many Ph-like ALL patients have genetic alterations that leave cancer cells vulnerable to available cancer drugs called ABL tyrosine kinase inhibitors (TKIs) and possibly other targeted therapies that are still experimental. Unlike conventional chemotherapy, TKIs kill more selectively and are less likely to damage healthy cells. Pui estimated that 20 percent of pediatric Ph-like ALL patients might be candidates for TKIs. "In the future, genetic testing will likely be used at diagnosis to identify Ph-like ALL and direct patients to the best targeted therapy, possibly including some drugs that are currently experimental," he said.
Ph-like ALL was first described in 2009 by two research groups, including investigators from St. Jude. The subtype is named for a chromosomal rearrangement known as the Philadelphia chromosome that is associated with a different ALL subtype. The Ph-positive and Ph-like ALL subtypes share similar patterns of gene expression. Patients with Ph-like ALL lack the fusion of the BCR and ABL1 genes that is a hallmark of Ph-positive ALL.
Previous studies of Ph-like ALL focused on high-risk patients whose treatment did not include risk-directed therapy based on MRD levels. This study included all eligible patients newly diagnosed with B-ALL who enrolled in the St Jude Total Therapy XV study between June 2000 and October 2007. Genomic testing was used to retrospectively diagnose Ph-like ALL.
MRD monitoring combined with conventional risk factors such as patient age and white blood count at diagnosis demonstrated that Ph-like ALL is not a uniformly high-risk disease. MRD also proved essential for identifying Ph-like ALL patients who can be cured with less-intensive chemotherapy. In this study, 40 percent of Ph-like ALL patients were classified with low-risk disease because they had other favorable clinical or biological features and no MRD at the end of remission induction, and received less-intensive treatment. Sixty percent of the 40 Ph-like ALL patients in this study were classified as having standard-risk or high-risk disease. The group included six patients who underwent bone marrow transplantation.
INFORMATION:
The study's first author is Kathryn Roberts, Ph.D., a St. Jude postdoctoral fellow. The other authors are Deqing Pei, Debbie Payne-Turner, Yongjin Li, Cheng Cheng, John Sandlund, Sima Jeha, John Easton, Jared Becksfort, Jinghui Zhang, Susana Raimondi, Wing Leung, Mary Relling, William Evans, James Downing and Charles Mullighan, all of St. Jude; and Dario Campana and Elaine Coustan-Smith, both formerly of St. Jude.
The study was funded in part by grants (CA21765, CA36401) from the National Cancer Institute (NCI) at the National Institutes of Health (NIH); a grant (GM92666) from the NIH; the National Health and Medical Research Council, Australia; The Leukemia & Lymphoma Society, Alex's Lemonade Stand Foundation; Stand Up to Cancer and ALSAC.
St. Jude Media Relations Contacts
Summer Freeman
desk (901) 595-3061
cell (901) 297-9861
summer.freeman@stjude.org
Carrie Strehlau
desk (901) 595-2295
cell (901) 297-9875
carrie.strehlau@stjude.org
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital is leading the way the world understands, treats and cures childhood cancer and other life-threatening diseases. It is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. Treatments developed at St. Jude have helped push the overall childhood cancer survival rate from 20 percent to 80 percent since the hospital opened more than 50 years ago. St. Jude is working to increase the overall survival rate for childhood cancer to 90 percent in the next decade. St. Jude freely shares the breakthroughs it makes, and every child saved at St. Jude means doctors and scientists worldwide can use that knowledge to save thousands more children. Families never receive a bill from St. Jude for treatment, travel, housing and food—because all a family should worry about is helping their child live. To learn more, visit stjude.org or follow St. Jude at @stjuderesearch.
Good news for young patients with a leukemia subtype associated with a poor prognosis
St. Jude Children's Research Hospital study shows that adjusting treatment based on early response to chemotherapy boosts survival of young patients with Philadelphia chromosome-like acute lymphoblastic leukemia
2014-09-24
ELSE PRESS RELEASES FROM THIS DATE:
Cardiorespiratory fitness is often misdiagnosed
2014-09-24
A recent study by the University of Eastern Finland shows that scaling maximal oxygen uptake and maximal workload by body weight confounds measures of cardiorespiratory fitness. It has been a common practice in exercise testing to scale the results by body weight and, according to researchers, this practice should be abandoned. More reliable data on cardiorespiratory fitness can be observed by using lean mass proportional measures. The results were published recently in Clinical Physiology and Functional Imaging.
Exercise tests, such as the maximal cycle ergometer exercise ...
'Greener,' low-cost transistor heralds advance in flexible electronics
2014-09-24
As tech company LG demonstrated this summer with the unveiling of its 18-inch flexible screen, the next generation of roll-up displays is tantalizingly close. Researchers are now reporting in the journal ACS Nano a new, inexpensive and simple way to make transparent, flexible transistors — the building blocks of electronics — that could help bring roll-up smartphones with see-through displays and other bendable gadgets to consumers in just a few years.
Yang Yang and colleagues note that transistors are traditionally made in a multi-step photolithography process, which ...
'Fracking' wastewater that is treated for drinking produces potentially harmful compounds
2014-09-24
Concerns that fluids from hydraulic fracturing, or "fracking," are contaminating drinking water abound. Now, scientists are bringing to light another angle that adds to the controversy. A new study, appearing in the ACS journal Environmental Science & Technology, has found that discharge of fracking wastewaters to rivers, even after passage through wastewater treatment plants, could be putting the drinking water supplies of downstream cities at risk.
William A. Mitch, Avner Vengosh and colleagues point out that the disposal of fracking wastewater poses a major challenge ...
Sam Houston State study finds gang life is short-lived
2014-09-24
HUNTSVILLE, TX 9/24/14 -- Although membership in a gang often is depicted as a lifelong commitment, the typical gang member joins at age 13 and only stays active for about two years, according to a study at Sam Houston State University.
"Gang membership is not a fixed identity or a scarlet letter," said David Pyrooz in an article published in the Journal of Quantitative Criminology. "Media and popular culture have led to misconceptions about gangs and gang membership, chief among them the myth of permanence, as reflected in the quote from West Side Story –'When you're ...
2-D materials' crystalline defects key to new properties
2014-09-24
Understanding how atoms "glide" and "climb" on the surface of 2D crystals like tungsten disulphide may pave the way for researchers to develop materials with unusual or unique characteristics, according to an international team of researchers.
"If we don't understand what is behind the materials' characteristics caused by these defects, then we can't engineer the right properties into devices," said Nasim Alem, assistant professor of materials science and engineering, Penn State. "With a closer look, we might find that some of the defects are no good, that we don't want ...
Wavefront optics emerging as new tool for measuring and correcting vision, reports Optometry and Vision Science
2014-09-24
September 24, 2014 – A technique developed by astronomers seeking a clear view of distant objects in space is being intensively studied as a new approach to measuring and correcting visual abnormalities. The October issue of Optometry and Vision Science, official journal of the American Academy of Optometry, is a theme issue devoted to research on wavefront refraction and correction. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
The special issue presents new research on the use of wavefront analysis for assessing subtle, ...
Nanotechnology leads to better, cheaper LEDs for phones and lighting
2014-09-24
Princeton University researchers have developed a new method to increase the brightness, efficiency and clarity of LEDs, which are widely used on smartphones and portable electronics as well as becoming increasingly common in lighting.
Using a new nanoscale structure, the researchers, led by electrical engineering professor Stephen Chou, increased the brightness and efficiency of LEDs made of organic materials (flexible carbon-based sheets) by 58 percent. The researchers also report their method should yield similar improvements in LEDs made in inorganic (silicon-based) ...
Pressure mounts on FDA and industry to ensure safety of food ingredients
2014-09-24
Confusion over a 1997 Food and Drug Administration (FDA) rule that eases the way for food manufacturers to use ingredients "generally regarded as safe," or GRAS, has inspired a new initiative by food makers. Food safety advocates say the current GRAS process allows substances into the food supply that might pose a health risk, while industry defends its record. An article in Chemical & Engineering News (C&EN) details what changes are on the table.
Melody M. Bomgardner, a senior editor at C&EN, explains that the rule, which was never finalized, was initially established ...
Higher risk of autism found in children born at short and long interpregnancy intervals
2014-09-24
Washington D.C., September 24, 2014 – A study published in the MONTH 2014 issue of the Journal of the American Academy of Child and Adolescent Psychiatry found that children who were conceived either less than 1 year or more than 5 years after the birth of their prior sibling were more likely to be diagnosed with autism than children conceived following an interval of 2-5 years.
Using data from the Finnish Prenatal Study of Autism (FIPS-A), a group of researchers led by Keely Cheslack-Postava, PhD, of Columbia University, analyzed records from 7371 children born between ...
Most breast cancer patients who had healthy breast removed at peace with decision
2014-09-24
ROCHESTER, Minn. — More women with cancer in one breast are opting to have both breasts removed to reduce their risk of future cancer. New research shows that in the long term, most have no regrets. Mayo Clinic surveyed hundreds of women with breast cancer who had double mastectomies between 1960 and 1993 and found that nearly all would make the same choice again. The findings are published in the journal Annals of Surgical Oncology.
The study made a surprising finding: While most women were satisfied with their decision whether they followed it with breast reconstruction ...
LAST 30 PRESS RELEASES:
New study unveils key strategies against drug-resistant prostate cancer
Northwestern Medicine, West Health, Meadows Mental Health Policy Institute collaboration to provide easier access to mental health care
New method reveals DNA methylation in ancient tissues, unlocking secrets of human evolution
Researchers develop clinically validated, wearable ultrasound patch for continuous blood pressure monitoring
Chromatwist wins innovate UK smart grant for £0.5M project
Unlocking the secrets of the first quasars: how they defy the laws of physics to grow
Study reveals importance of student-teacher relationships in early childhood education
Do abortion policy changes affect young women’s mental health?
Can sown wildflowers compensate for cities’ lack of natural meadows to support pollinating insects?
Is therapeutic hypothermia an effective treatment for hypoxic-ischemic encephalopathy, a type of neurological dysfunction in newborns?
Scientists discover the molecular composition of potentially deadly venomous fish
What are the belowground responses to long-term soil warming among different types of trees?
Do area-wide social and environmental factors affect individuals’ risk of cognitive impairment?
UCLA professor Helen Lavretsky reshapes brain health through integrative medicine research
Astronauts found to process some tasks slower in space, but no signs of permanent cognitive decline
Larger pay increases and better benefits could support teacher retention
Researchers characterize mechanism for regulating orderly zygotic genome activation in early embryos
AI analysis of urine can predict flare up of lung disease a week in advance
New DESI results weigh in on gravity
New DESI data shed light on gravity’s pull in the universe
Boosting WA startups: Report calls for investment in talent, diversity and innovation
New AEM study highlights feasibility of cranial accelerometry device for prehospital detection of large-vessel occlusion stroke
High cardiorespiratory fitness linked to lower risk of dementia
Oral microbiome varies with life stress and mental health symptoms in pregnant women
NFL’s Arizona Cardinals provide 12 schools with CPR resources to improve cardiac emergency outcomes
Northerners, Scots and Irish excel at detecting fake accents to guard against outsiders, Cambridge study suggests
Synchronized movement between robots and humans builds trust, study finds
Global experts make sense of the science shaping public policies worldwide in new International Science Council and Frontiers Policy Labs series
The Wistar Institute and Cameroon researchers reveals HIV latency reversing properties in African plant
$4.5 million Dept. of Education grant to expand mental health services through Binghamton University Community Schools
[Press-News.org] Good news for young patients with a leukemia subtype associated with a poor prognosisSt. Jude Children's Research Hospital study shows that adjusting treatment based on early response to chemotherapy boosts survival of young patients with Philadelphia chromosome-like acute lymphoblastic leukemia